Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
SNWV
$0.17
Sanuwave Health
($.02)
(8.50%)
SNWV
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus: $0.00
Revenue: $3.00 Mil
Tuesday
Mar 16
9:00 AM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Tuesday, November 17, 2020
SANUWAVE Health Reports Third Quarter 2020 Financial Results
What do you expect when SNWV reports earnings?
Beat
Meet
Miss
Where is SNWV's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$0.22
$0.21
$0.19
$0.18
Support
$0.16
$0.15
$0.13
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
Peers
Biogen
Amgen
Gilead Sciences
Neurocrine Biosciences
Bluebird Bio
Seattle Genetics
Qiagen N.V.
BioCryst Pharmaceuticals
Sangamo Therapeutics
Bio-Techne
Expectations
›
Sanuwave Health